ArticlePloS one2014

Serum complement C3f and fibrinopeptide A are potential novel diagnostic biomarkers for non-alcoholic fatty liver disease: a study in Qingdao Twins.

Yong-Ning Xin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.